» Articles » PMID: 12730337

Reduced Nephron Number in Adult Sheep, Hypertensive As a Result of Prenatal Glucocorticoid Treatment

Overview
Journal J Physiol
Specialty Physiology
Date 2003 May 6
PMID 12730337
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

There is some evidence, mainly from rodent studies, that any factor which alters the final total number of nephrons formed, during nephrogenesis, will result in hypertension in adult life. Sheep, programmed to become hypertensive by exposure to synthetic glucocorticoid (dexamethasone, 0.48 mg h-1, for 48 h) early in development (~27 days of gestation), were killed at 7 years of age, and had nephron counting performed by unbiased stereology. Mean arterial pressure was 83 +/- 4 mmHg in the dexamethasone (DEX) group (n = 5), and 73 +/- 5 in the control (CON; n = 7; P < 0.05). The total nephron number, in the right kidney (249 070 +/- 14 331; n = 5) was significantly lower (P < 0.01) than that of controls (402 787 +/- 30 458; n = 7). Mean glomerular volume was larger in the DEX than the CON group (P < 0.01), but there was no significant difference in the sclerosis index between the two groups. Low nephron number was associated with grossly enlarged and dilated proximal tubules and greater accumulation of collagen type I and type III in the tubular interstitium and periadventitia of the renal cortical vessels. These data suggest that the hypertensive programming effect of glucocorticoid treatment, early in kidney development, results, at least in part, from impaired nephrogenesis.

Citing Articles

Respiratory distress syndrome is the poster child for neonatology.

Jobe A Pediatr Res. 2025; .

PMID: 39821130 DOI: 10.1038/s41390-024-03723-1.


Progression of serum creatinine and glomerular filtration rate in neonatal critical care patients during the first seven days of life.

Medina Munoz M, Canto Cerdan M, Matias Del Pozo V, Pino Vazquez A, Alcaraz Romero A, Tarraga Lopez P Pediatr Nephrol. 2025; .

PMID: 39775937 DOI: 10.1007/s00467-024-06631-y.


Prenatal glucocorticoids exposure and adverse cardiovascular effects in offspring.

Zhao C, He L, Li L, Deng F, Zhang M, Wang C Front Endocrinol (Lausanne). 2024; 15:1430334.

PMID: 39351527 PMC: 11439645. DOI: 10.3389/fendo.2024.1430334.


Guidelines for in vivo models of developmental programming of cardiovascular disease risk.

Warrington J, Collins H, Davidge S, do Carmo J, Goulopoulou S, Intapad S Am J Physiol Heart Circ Physiol. 2024; 327(1):H221-H241.

PMID: 38819382 PMC: 11380980. DOI: 10.1152/ajpheart.00060.2024.


The Kidney-Gut Axis as a Novel Target for Nutritional Intervention to Counteract Chronic Kidney Disease Progression.

Cabala S, Ozgo M, Herosimczyk A Metabolites. 2024; 14(1).

PMID: 38276313 PMC: 10819792. DOI: 10.3390/metabo14010078.


References
1.
Bertram C, Trowern A, Copin N, Jackson A, Whorwood C . The maternal diet during pregnancy programs altered expression of the glucocorticoid receptor and type 2 11beta-hydroxysteroid dehydrogenase: potential molecular mechanisms underlying the programming of hypertension in utero. Endocrinology. 2001; 142(7):2841-53. DOI: 10.1210/endo.142.7.8238. View

2.
Bertram J, Young R, Spencer K, Gordon I . Quantitative analysis of the developing rat kidney: absolute and relative volumes and growth curves. Anat Rec. 2000; 258(2):128-35. DOI: 10.1002/(SICI)1097-0185(20000201)258:2<128::AID-AR2>3.0.CO;2-P. View

3.
Nolan C, Norman J, Page W, Miller P, Meyer T . Forty-five year follow-up after uninephrectomy. Kidney Int. 1993; 43(5):1110-5. DOI: 10.1038/ki.1993.156. View

4.
Welham S, Wade A, Woolf A . Protein restriction in pregnancy is associated with increased apoptosis of mesenchymal cells at the start of rat metanephrogenesis. Kidney Int. 2002; 61(4):1231-42. DOI: 10.1046/j.1523-1755.2002.00264.x. View

5.
Caspari P, Newcomb M, Gibson K, Harris P . Collagen in the normal and hypertrophied human ventricle. Cardiovasc Res. 1977; 11(6):554-8. DOI: 10.1093/cvr/11.6.554. View